Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment? [electronic resource]
Producer: 20140902Description: 23 p. digitalISSN:- 1471-2407
- Adult
- Bone Neoplasms -- diagnostic imaging
- Chemotherapy, Adjuvant
- Disease Progression
- Disease-Free Survival
- Facial Bones -- diagnostic imaging
- Fluorodeoxyglucose F18
- Humans
- Kaplan-Meier Estimate
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multimodal Imaging
- Necrosis
- Neoadjuvant Therapy
- Neoplasm Recurrence, Local
- Osteosarcoma -- diagnostic imaging
- Positron-Emission Tomography
- Predictive Value of Tests
- Radiopharmaceuticals
- Retrospective Studies
- Skull -- diagnostic imaging
- Time Factors
- Tomography, X-Ray Computed
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.